drugset
drugset / Trial / NCT02221830

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

NCT02221830 ↗

Phase 0 Completed 66 enrolled University of Colorado, Denver
RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluation of the efficacy of postpartum 24 hour oxytocin infusion to reduce blood loss in patients with pre-eclampsia (PE)

Timeline

Start
2015-02
Primary completion
2019-07-17
Completion
2019-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — —

Indications

preeclampsia